News
Opinion
3hOpinion
The Star on MSNNYIKAL, LANG'AT & OTINDO: Kenya at crossroads - Call for courage in HIV responseConference on HIV Science on July 17 in Kigali, one message echoed with urgency across Africa—and especially in Kenya: the global HIV response is at a turning point. IAS 2025 was not just a conference ...
Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital ...
Kenya missed its male circumcision target for the year ending June 2024 by more than 31,000 procedures, jeopardising its strategic goals of reducing new HIV infections, sexually transmitted ...
US president-elect Donald Trump after a meeting at The Elysee Presidential Palace in Paris on December 7, 2024. Trump makes his first international trip since his election win, preparing for a day ...
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally ...
These are the words of Rogers Omollo, founder and CEO of Activate Action – a youth-led non-profit organisation that supports ...
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute to design and test novel delivery models for HIV services.
KIGALI, Rwanda — The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV ...
PEPFAR has written a memo to all countries where it runs programmes. According to the memo, all funding, including new and existing, will be suspended for at least 90 days to allow for an evaluation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results